T1	Subject 125 142	73-year-old woman
T3	Anatomical_entity 966 980	lung structure
T6	Anatomical_entity 517 521	lung
T7	Organic_compound_other 148 154	CA19-9
T8	Disorder 1048 1071	diffuse alveolar damage
T11	GGPs 761 764	mAb
T12	Method_cue 690 718	Immunohistochemical staining
T14	Cellular_process 593 612	squamous metaplasia
T15	Disorder 165 198	idiopathic interstitial pneumonia
T17	Anatomical_entity 831 842	bronchiolar
T19	Disorder 665 688	diffuse alveolar damage
T20	Disorder 18 47	idiopathic pulmonary fibrosis
T22	Artificial_process 455 462	therapy
T25	Disorder 577 587	hemorrhage
T29	Localization 776 788	localization
T33	Cell 843 859	epithelial cells
T34	Disorder 53 76	diffuse alveolar damage
T37	Disorder 549 575	hyaline membrane formation
T40	Anatomical_entity 346 351	serum
T41	Organic_compound_other 885 891	CA19-9
T44	Subject 486 493	patient
T46	GGPs 744 747	mAb
T47	Method_cue 264 281	Chest radiography
T50	Method_cue 286 305	computed tomography
E1	Cellular_process:T14 Cue2:T16 Cue:T16 atLoc:T6
E2	Artificial_process:T22 
E4	Localization:T29 Theme:T64 Cue:T69 Cue2:T12 atLoc:T33
N3	Reference T1 UMLS:C0043210	Woman
N10	Reference T3 UMLS:C0024109	Lung
N27	Reference T6 UMLS:C0024109	Lung
N30	Reference T7 UMLS:C0006613	CA-19-9 Antigen
N31	Reference T8 UMLS:C1262020	diffuse alveolar damage
N39	Reference T11 UMLS:C0003250	Monoclonal Antibodies
N52	Reference E1 UMLS:C0025570	Squamous metaplasia
N55	Reference T15 UMLS:C2350236	Idiopathic Interstitial Pneumonias
N59	Reference T17 UMLS:C0006270	Bronchioles
N62	Reference T19 UMLS:C1262020	diffuse alveolar damage
N64	Reference T20 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N74	Reference E2 UMLS:C0087111	Therapeutic procedure
N81	Reference T25 UMLS:C0019080	Hemorrhage
N107	Reference T33 UMLS:C0014597	Epithelial Cells
N111	Reference T34 UMLS:C1262020	diffuse alveolar damage
N128	Reference T37 UMLS:C0333563	Hyaline membrane
N137	Reference T40 UMLS:C0229671	Serum
N140	Reference T41 UMLS:C0006613	CA-19-9 Antigen
N150	Reference T44 UMLS:C0030705	Patients
N158	Reference T46 UMLS:C0003250	Monoclonal Antibodies
N160	Reference T47 UMLS:C0039985	Plain chest X-ray
N165	Reference T50 UMLS:C0040405	X-Ray Computed Tomography
T53	Biological_process 630 648	acute exacerbation
E8	Biological_process:T53 
N1	Reference E8 UMLS:C0743630	exacerbation acute
T5	Organic_compound_other 1 7	CA19-9
N4	Reference T5 UMLS:C0006613	CA-19-9 Antigen
T56	Organic_compound_other 352 358	CA19-9
N5	Reference T56 UMLS:C0006613	CA-19-9 Antigen
T57	Organic_compound_other 737 743	CA19-9
N8	Reference T57 UMLS:C0006613	CA-19-9 Antigen
T58	Organic_compound_other 792 798	CA19-9
N9	Reference T58 UMLS:C0006613	CA-19-9 Antigen
T59	GGPs 98 102	KL-6
N11	Reference T59 UMLS:C0057628	Mucin-1 protein
T60	GGPs 415 419	KL-6
N13	Reference T60 UMLS:C0057628	Mucin-1 protein
T61	GGPs 756 760	KL-6
N16	Reference T61 UMLS:C0057628	Mucin-1 protein
T63	GGPs 982 986	KL-6
N18	Reference T63 UMLS:C0057628	Mucin-1 protein
T64	GGPs 803 815	KL-6 antigen
N19	Reference T64 UMLS:C0057628	Mucin-1 protein
T21	Biological_process 438 450	exacerbation
E9	Biological_process:T21 
N17	Reference E9 UMLS:C4086268	Exacerbation
T23	Biological_process 251 262	exacerbated
E10	Biological_process:T23 
N20	Reference E10 UMLS:C1444749	Exacerbated
R1	Subject_Disorder Arg1:T1 Arg2:T15	
T26	Positive_regulation 420 429	increased
E3	Positive_regulation:T26 Theme:T60
N2	Reference E3 UMLS:C1879547	Activation action
T28	Disorder 327 340	patchy shadow
N21	Reference T28 UMLS:C0476367	Shadow of lung
T38	Biological_process 8 17	producing
E6	Biological_process:T38 Theme:T5 disorder:T20
T9	Biological_process 155 164	producing
E11	Biological_process:T9 Theme:T7 disorder:T15
T27	Positive_regulation 653 661	resulted
E12	Positive_regulation:T27 Cause:E8 Theme:T19 Cue:T49
N24	Reference E12 UMLS:C1879547	Activation action
E13	Localization:T29 Theme:T58 atLoc:T33 Cue:T68 Cue2:T12
R2	part_of Arg1:T33 Arg2:T17	
R3	Disorder_association Arg1:T20 Arg2:T34	
T18	Biological_process 494 498	died
E5	Biological_process:T18 Theme:T44
N26	Reference E5 UMLS:C0011065	Cessation of life
T32	Regulation 467 476	effective
E7	Regulation:T32 Cue:T35 Theme:E2
N29	Reference E7 UMLS:C1327622	Regulation of biological process
T35	Negation_cue 452 454	No
A1	Negated E7
N33	Reference T12 UMLS:C0021044	Immunohistochemistry
T45	Artificial_process 107 114	autopsy
E15	Artificial_process:T45 Theme:T62
N35	Reference E15 UMLS:C0004398	Autopsy
T16	Method_cue 534 541	autopsy
T49	Speculation_cue 614 624	suggesting
T54	Speculation_cue 542 548	showed
T43	Biological_process 549 575	hyaline membrane formation
E14	Biological_process:T43 Cue:T54 Cue2:T16 atLoc:T6
N34	Reference E14 UMLS:C0333563	Hyaline membrane
T55	Biological_process 577 587	hemorrhage
E16	Biological_process:T55 Cue:T54 Cue2:T16 atLoc:T6
N40	Reference E16 UMLS:C0019080	Hemorrhage
N37	Reference T16 UMLS:C0004398	Autopsy
T68	Speculation_cue 765 771	showed
T69	Speculation_cue 765 771	showed
N22	Reference E6 UMLS:C0220781	Anabolism
N23	Reference E11 UMLS:C0220781	Anabolism
N28	Reference E4 UMLS:C1744691	establishment and maintenance of localization
N25	Reference E13 UMLS:C1744691	establishment and maintenance of localization
T62	Subject 115 119	case
N32	Reference T62 UMLS:C0030705	Patients
T39	GGPs 732 747	anti-CA19-9 mAb
R4	member_of Arg1:T39 Arg2:T46	
T65	GGPs 751 764	anti-KL-6 mAb
R5	member_of Arg1:T65 Arg2:T11	
